Skip to main content
Nature Communications logoLink to Nature Communications
. 2022 Aug 25;13:4978. doi: 10.1038/s41467-022-32722-1

Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy

Jing Gao 1,2, Bo Hou 2,3, Qiwen Zhu 2, Lei Yang 4, Xingyu Jiang 4, Zhifeng Zou 2,3, Xutong Li 2, Tianfeng Xu 2, Mingyue Zheng 2, Yi-Hung Chen 5, Zhiai Xu 3,, Huixiong Xu 6,, Haijun Yu 2,4,
PMCID: PMC9411121  PMID: 36008490

Correction to: Nature Communications 10.1038/s41467-022-32050-4, published online 26 July 2022

The original version of this Article contained an error in Figures 6k (PED + N3@PGDA7 + Laser) and 6l (PED + N3@PGDA7), in which the images were duplicates of adjacent images and the correct images were missing. This has been corrected in both the PDF and HTML versions of the Article.

Contributor Information

Zhiai Xu, Email: zaxu@chem.ecnu.edu.cn.

Huixiong Xu, Email: xu.huixiong@zs-hospital.sh.cn.

Haijun Yu, Email: hjyu@simm.ac.cn.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES